Key Companies - Suboxone Industry

Throughout the projected period, the market growth is anticipated to be driven by the rising number of regulatory approvals and launches for generic versions of suboxone. For instance, Rhodes Pharmaceuticals, a division of Purdue, a privately held American pharmaceutical company, created a generic medicine buprenorphine and naloxone tablet that the U.S. Food and Drug Administration (FDA) approved in 2020. Suboxone is an opioid addiction treatment drug that is available only by prescription. Opioids are potent analgesics that are also very addicting. Hence during the course of the forecast period, rising opioid use is anticipated to lead to rising demand for suboxone for the treatment of opioid addiction.

The global Suboxone Market is estimated to be valued at US$ 6,163.9 million in 2022 and is expected to exhibit a CAGR of 4.0% during the forecast period (2022-2030).

Prominent Companies in the Suboxone Industry:

1. Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and others segments.  Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.  Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. On Feb 2021, Dr. Reddy’s Laboratories has introduced an orally disintegrating formulation of lansoprazole to the U.S. market. Lansoprazole is a proton pump inhibitor, a mechanism of action designed to reduce the amount of acid made in the stomach and thereby treat conditions including indigestion, heartburn, acid reflux and gastroesophageal reflux disease.

2. Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC was founded in 2002 and since then developes, licenses, manufactures, markets and distributes generic and speciality pharmaceutical products. The company headquarters are situated in Bridgewater, New Jersey. Amneal Pharmaceuticals LLC in November, 2022 announced the commercial launch of RELEUKO a biosimilar referencing Neupogen RELEUKO used to treat neutropenia. 

3. Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company was founded in 1983 and is based in Mumbai, India 

4. Novartis AG

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol.

5. Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

6. Alkem Labs

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company was incorporated in 1973 and is headquartered in Mumbai, India.

7. Hikma Pharmaceuticals PLC.

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company was founded in 1978 and is based in London, the United Kingdom. In January, 2023 Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreement with Celltrion Healthcare Co., Ltd, a global biopharmaceutical company.

8. Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

9. Mallinckrodt

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. The company was founded in 1867 and is based in Dublin, Ireland.

10. Lannett Co Inc.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

*Definition -

Suboxone is a drug used to treat opioid (narcotic) drug dependence in people who are addicted to heroin or morphine. Adults and children over the age of 15 who also need medical, social, and psychiatric care are prescribed Suboxone.